about
Host-Species Transferrin Receptor 1 Orthologs Are Cellular Receptors for Nonpathogenic New World Clade B ArenavirusesDifferences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: Implications for receptor usage and pathogenicityMachupo virus glycoprotein determinants for human transferrin receptor 1 binding and cell entry.Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transportDrug discovery technologies and strategies for Machupo virus and other New World arenaviruses.Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses.Pathogenesis of arenavirus hemorrhagic fevers.The curious case of arenavirus entry, and its inhibition.Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization.Cell entry by human pathogenic arenaviruses.Junin virus infects mouse cells and induces innate immune responses.Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses.Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242.Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus.Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan.Novel drug discovery approaches for treating arenavirus infections.Sodium hydrogen exchangers contribute to arenavirus cell entry.siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target.Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors.Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GPInvestigation of clade B New World arenavirus tropism by using chimeric GP1 proteins.Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticlesDifferent mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1.Receptor use by the Whitewater Arroyo virus glycoprotein.Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses.Retrovirus-Based Surrogate Systems for BSL-2 High-Throughput Screening of Antivirals Targeting BSL-3/4 Hemorrhagic Fever-Causing Viruses.Studies of Lassa Virus Cell Entry.Altering α-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropismTIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus.Retroviral Pseudotypes - From Scientific Tools to Clinical Utility
P2860
Q27488235-E6E94937-BB1A-4598-8506-5E1CF24FD0A5Q27489608-9E08605B-3B70-438A-BE35-E14AEAC05180Q33959298-60B5F966-9202-4633-A4D3-94D6BB6C2C25Q34023003-28F480EB-9B8B-4B0E-ADA5-896243EF6BB1Q34274569-10DE39AD-3207-460A-B637-638AFE019AB5Q34588241-61E2E3EE-05D5-4AD7-A395-B7D4DE9C1711Q34625899-8D5C359D-D55A-447F-AE45-99AA17C59DD1Q34636037-A9731B58-AFF3-4849-80D6-5BE763F72389Q34719449-DD17B7A5-73FF-4FAC-8AB2-CD0D8CF9F0B7Q34734128-6F0D260F-E7B3-4D8F-A62A-99844B5F93B8Q35363337-77030489-04AE-4472-B5D1-9BB280CA5CD0Q35399369-8006A83E-2BCB-4A2A-8022-477420742F4BQ35652155-3E6AD7B8-2147-4295-8D48-7A5DB7C2B897Q35774829-27293F1C-DC09-4EEC-B736-EC81ABC7C9E6Q37336878-414BA2E8-A1EE-4D0C-A9F6-26E28F7E0BA1Q37406952-71212AF5-C892-41AB-A23A-30E3FEDEB6A4Q38735837-3799DD6A-7016-42FE-8690-3AAD82341FC1Q39068701-C29E1473-32A0-481B-BDAD-1DBA151DD222Q39091684-C47FDF7D-6DCB-4D7A-B7AC-B07131967270Q39363423-FA675B77-1F89-4217-BA08-74BF80AB6FC8Q39462623-0BFFFD3F-A98D-4174-ABBD-AED4DE325716Q39778977-EB8CB77F-9C7E-4BE9-876C-27D8488DB608Q39893565-EE692353-99E1-4583-BE89-3C1D8AE84E2BQ39977616-7DC2370B-75ED-4016-A91A-BC874AAC7A0DQ40051850-9DBD2B2D-9C14-4626-9605-5E3B1B9B991BQ40053143-EA909D1F-FE92-43F2-865C-27703EAEB66AQ40316605-B0269682-F67E-48CA-A8FE-E2ABDBD92736Q41922316-FA1EEFC7-F237-4239-9BC5-E18D632B6701Q41922444-A84E1EBC-1133-43EC-AAD6-BC5346F9C3F8Q41980779-DD056916-CA13-4B6C-92D3-725D8B9CF64EQ55084398-BA629C52-1E02-4611-BDE3-31E6CF2A0C2AQ58382398-CAD3010D-1A7B-4D43-BB1F-949B74F14BBB
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Receptor use by pathogenic arenaviruses.
@en
type
label
Receptor use by pathogenic arenaviruses.
@en
prefLabel
Receptor use by pathogenic arenaviruses.
@en
P2093
P1433
P1476
Receptor use by pathogenic arenaviruses.
@en
P2093
Beth Noble
Erika Lamb
Jill Oldenburg
Michael J Buchmeier
Paula M Cannon
Therese Reignier
Victor Romanowski
P304
P356
10.1016/J.VIROL.2006.05.018
P407
P577
2006-06-21T00:00:00Z